STERIS EBITDA Margin 2010-2022 | STE

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for STERIS (STE) over the last 10 years. The current EBITDA margin for STERIS as of June 30, 2022 is .
STERIS EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2022-06-30 $4.77B $1.25B 26.08%
2022-03-31 $4.59B $1.05B 22.81%
2021-12-31 $4.25B $0.94B 22.20%
2021-09-30 $3.85B $0.83B 21.44%
2021-06-30 $3.41B $0.70B 20.58%
2021-03-31 $3.11B $0.77B 24.71%
2020-12-31 $3.06B $0.77B 25.32%
2020-09-30 $3.02B $0.76B 25.22%
2020-06-30 $3.00B $0.74B 24.71%
2020-03-31 $3.03B $0.73B 24.22%
2019-12-31 $2.98B $0.72B 24.06%
2019-09-30 $2.90B $0.68B 23.33%
2019-06-30 $2.84B $0.65B 22.99%
2019-03-31 $2.78B $0.64B 22.90%
2018-12-31 $2.73B $0.60B 22.09%
2018-09-30 $2.70B $0.60B 22.22%
2018-06-30 $2.65B $0.59B 22.26%
2018-03-31 $2.62B $0.58B 22.06%
2017-12-31 $2.59B $0.53B 20.54%
2017-09-30 $2.57B $0.50B 19.42%
2017-06-30 $2.58B $0.48B 18.40%
2017-03-31 $2.61B $0.47B 18.11%
2016-12-31 $2.62B $0.52B 19.65%
2016-09-30 $2.59B $0.49B 18.94%
2016-06-30 $2.44B $0.42B 17.11%
2016-03-31 $2.24B $0.36B 15.94%
2015-12-31 $2.05B $0.30B 14.38%
2015-09-30 $1.91B $0.29B 15.01%
2015-06-30 $1.88B $0.32B 17.09%
2015-03-31 $1.85B $0.32B 17.23%
2014-12-31 $1.81B $0.31B 17.03%
2014-09-30 $1.75B $0.30B 17.23%
2014-06-30 $1.67B $0.29B 17.27%
2014-03-31 $1.62B $0.28B 17.38%
2013-12-31 $1.59B $0.29B 18.16%
2013-09-30 $1.56B $0.30B 19.10%
2013-06-30 $1.53B $0.31B 20.10%
2013-03-31 $1.50B $0.31B 20.79%
2012-12-31 $1.46B $0.32B 21.67%
2012-09-30 $1.44B $0.30B 21.00%
2012-06-30 $1.43B $0.29B 20.14%
2012-03-31 $1.41B $0.29B 20.26%
2011-12-31 $1.40B $0.27B 19.07%
2011-09-30 $1.37B $0.25B 17.91%
2011-06-30 $1.34B $0.25B 18.70%
2011-03-31 $1.21B $0.14B 11.52%
2010-12-31 $1.16B $0.13B 11.46%
2010-09-30 $1.16B $0.16B 13.61%
2010-06-30 $1.16B $0.15B 13.24%
2010-03-31 $1.26B $0.26B 20.75%
2009-12-31 $1.27B $0.26B 20.31%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $17.307B $4.585B
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.023B 21.80
Edwards Lifesciences (EW) United States $54.208B 38.35
Alcon (ALC) Switzerland $30.150B 25.53
Teleflex (TFX) United States $9.641B 15.36
Fresenius Medical Care AG KGaA (FMS) Germany $8.287B 7.64
Penumbra (PEN) United States $7.435B 891.96
Globus Medical (GMED) United States $6.225B 31.75
Glaukos (GKOS) United States $2.693B 0.00
Integer Holdings (ITGR) United States $2.196B 17.17
Nevro (NVRO) United States $1.739B 0.00
Paragon 28 (FNA) United States $1.384B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.081B 16.55
Artivion (AORT) United States $0.519B 49.50